Stem cells in the treatment of central nervous system disease
- PMID: 29523970
- PMCID: PMC5878184
- DOI: 10.1007/s00415-018-8818-7
Stem cells in the treatment of central nervous system disease
Comment on
-
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.Lancet Neurol. 2017 May;16(5):360-368. doi: 10.1016/S1474-4422(17)30046-7. Epub 2017 Mar 17. Lancet Neurol. 2017. PMID: 28320635 Clinical Trial.
-
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.Nature. 2017 Aug 30;548(7669):592-596. doi: 10.1038/nature23664. Nature. 2017. PMID: 28858313
-
Cell-based therapeutic strategies for multiple sclerosis.Brain. 2017 Nov 1;140(11):2776-2796. doi: 10.1093/brain/awx154. Brain. 2017. PMID: 29053779 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
